3E Bioventures Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 115

  • Portfolio
  • 73

  • Exits
  • 21

Exits

3E Bioventures Capital General Information

Description

Founded in 2015, 3E Bioventures Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest in companies operating in the life sciences and biomedical technology sectors.

Contact Information

Website
www.3ebiovc.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 228 Hamilton Avenue
  • 3rd floor
  • Palo Alto, CA 94301
  • United States

3E Bioventures Capital Investments (115)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
KingAgroot 08-Aug-2023 Later Stage VC Agricultural Chemicals Generating Revenue
0-00000000 0000000 19-Jul-2023 00000 00000 000.00 Diagnostic Equipment Generating Revenue
00000000 000000000 23-May-2023 00000 00000 000.00 Biotechnology Startup 00000 000 00.0
0000000 0000000000 27-Apr-2023 00000 00000 Environmental Services (B2B) Startup
000000000 17-Apr-2023 00000 00000 00.00 Monitoring Equipment Generating Revenue
0000000 000 24-Feb-2023 00000 00000 0000 Diagnostic Equipment Generating Revenue
00000000 000000000 14-Feb-2023 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
00000000 00 07-Feb-2023 00000 00000 Biotechnology Generating Revenue
Junhemeng 16-Jan-2023 Early Stage VC 000.00 Drug Delivery Generating Revenue
JUSHU 13-Jan-2023 Early Stage VC 00.000 Biotechnology Generating Revenue
You’re viewing 10 of 115 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

3E Bioventures Capital Exits (21)

Company Name Exit Date Exit Type Exit Size
Cardea 29-Apr-2023 Merger/Acquisition
000 00000000000 02-Sep-2022 000 00000
0000000000 01-Sep-2022 000 000.00
000000 00000000000 05-Aug-2022 000 00000
00000000 01-Aug-2022 0000000 000000
000000000 00000000 08-Oct-2021 000 000.00
00000 23-Jul-2021 000 00000
0000000000 01-Dec-2020 000000000000000000 00000
C4 Therapeutics 02-Oct-2020 IPO 00000
Eucure Biopharma 24-Sep-2020 Merger/Acquisition
You’re viewing 10 of 21 exits. Get the full list »

3E Bioventures Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

3E Bioventures Capital Team (14)

Name Title Deals Funds Boards Office
Francine Fang Ph.D Co-Founding Partner & Managing Partner 0 0 Beijing, China
Qianye Liu Ph.D Co-Founding Partner & Managing Partner 00 0 0 Beijing, China
Jin Li Ph.D Co-Founding Partner 0 Beijing, China
Joy Yang Ph.D Venture Partner Beijing, China
Frank Yan Ph.D Partner 0 0 0 Beijing, China
You’re viewing 5 of 14 team members. Get the full list »

3E Bioventures Capital Co-Investors (194)

Name With Exits Lead Partner Series Industry
Lilly Asia Ventures 4 0 Series chart Industry bar
Yijing Capital 0 Series chart Industry bar
Co-Stone Capital 0 Series chart Industry bar
Foothill Ventures 0 0 0 Series chart Industry bar
Northern Light Venture Capital 0 0 Series chart Industry bar
You’re viewing 5 of 194 co-investors. Get the full list »